ReviewJournal of personalized medicine2023

Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives.

Antonio Sanz-Solas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.